However, given the absence of acromegalic clinical features and lack of biochemical confirmation, acromegaly was not diagnosed in either case.<h4>Conclusion</h4>Routine IGF-1 screening in all patients with poorly controlled type 2 DM has limited diagnostic yield. This evidence concerns the gene IGF1 and acromegaly.